Toggle light / dark theme

Computer scientists from Duke University and Harvard University have joined with physicians from Massachusetts General Hospital and the University of Wisconsin to develop a machine learning model that can predict which patients are most at risk of having destructive seizures after suffering a stroke or other brain injury.

A point system they’ve developed helps determine which patients should receive expensive continuous electroencephalography (cEEG) monitoring. Implemented nationwide, the authors say their could help hospitals monitor nearly three times as many patients, saving many lives as well as $54 million each year.

A paper detailing the methods behind the interpretable machine learning approach appeared online June 19 in the Journal of Machine Learning Research.

Awesome!


A new approach to programing cancer-fighting immune cells called CAR-T cells can prolong their activity and increase their effectiveness against human cancer cells grown in the laboratory and in mice, according to a study by researchers at the Stanford University School of Medicine.

The ability to circumvent the exhaustion that the genetically engineered cells often experience after their initial burst of activity could lead to the development of a new generation of CAR-T cells that may be effective even against solid cancers—a goal that has until now eluded researchers.

The studies were conducted in mice harboring human leukemia and . The researchers hope to begin in people with leukemia within the next 18 months and to eventually extend the trials to include solid cancers.

“It’s the first chip implanted into the human brain”
►Special thanks to our friends from London Real for this amazing interview. Subscribe to their channel:
https://www.youtube.com/user/LondonRealTV

►OUR CLOTHING LINE : http://bit.ly/2HMI0oF

► If you struggle and have a hard time, consider taking an online therapy session with our partner BetterHelp. http://tryonlinetherapy.com/beinspired

►Motivational Alarm Tones

Over 116,000 people in the US are on organ transplant waiting lists because of a shortage in healthy donated organs. Dr. Wells and his team have been harnessing the power of stem cells to grow miniature versions of human organs in the laboratory. Today, mini organs are being used to help diagnose patients and improve care and Dr. Wells and colleagues are working to generate lab grown organs for future transplantation into patients. Screen reader support enabled. FB: James Wells, LinkedIn: James Wells As a Developmental Biologist, Jim Wells has spent the past two decades trying to uncover how a single cell gives rise to tissues, organs and eventually a whole organism. With this information as a roadmap, he has pioneered approaches to generate mini organs (organoids) from stem cells in the laboratory. Dr. Wells is now part of a team that is using tissue engineering to generate bigger and more functional organs in the lab that can be used for transplantation into patients in the future. Dr. Wells is a professor of Pediatrics at the Cincinnati Children’s Hospital Medical Center. He is in the Division of Developmental Biology and where he established the human pluripotent stem cell facility. He is also the Director for Basic Research in the Division of Endocrinology and was appointed Chief Scientific Officer of the Center for Stem Cell and Organoid Medicine. As a Developmental Biologist, Jim Wells has spent the past two decades trying to uncover how a single cell gives rise to tissues, organs and eventually a whole organism. With this information as a roadmap, he has pioneered approaches to generate mini organs (organoids) from stem cells in the laboratory. Dr. Wells is now part of a team that is using tissue engineering to generate bigger and more functional organs in the lab that can be used for transplantation into patients in the future. Dr. Wells is a professor of Pediatrics at the Cincinnati Children’s Hospital Medical Center. He is in the Division of Developmental Biology and where he established the human pluripotent stem cell facility. He is also the Director for Basic Research in the Division of Endocrinology and was appointed Chief Scientific Officer of the Center for Stem Cell and Organoid Medicine. This talk was given at a TEDx event using the TED conference format but independently organized by a local community.

Ethical concerns about new and emerging technologies that could significantly extend human lifespans generally focus on their potential impact on individuals and the permissibility of providing such treatment options. Because these technologies might also prompt us to assess and balance interests of different individuals and groups, given resource and production limitations, life-extension technologies provoke profound conversations about the nature and value of traditional conceptions of humanity.


Life extension requires careful consideration of resource scarcity, justice, and what, if anything, is intrinsic to the experiences we define as human.

NEW YORK (AP) — The U.S. winter flu season is off to its earliest start in more than 15 years.

An early barrage of illness in the South has begun to spread more broadly, and there’s a decent chance flu season could peak much earlier than normal, health officials say.

The last flu season to rev up this early was in 2003–2004 — a bad one. Some experts think the early start may mean a lot of suffering is in store, but others say it’s too early to tell.